Boehringer Ingelheim's experimental drug, survodutide, has shown significant potential in reducing liver fat accumulation, a condition known as MASLD/MASH. Presented at the American Diabetes Association (ADA) annual meeting, the drug targets both weight loss and metabolic health, offering a new approach beyond traditional obesity treatments.
A Taiwanese team has developed an AI platform called "AI+MASH" that can detect and quantify fat droplets in liver cells with 98% accuracy. This technology significantly speeds up the analysis process, aiding in drug development and precision medicine for liver diseases.
US stock markets reached new record highs on Friday as Apple rose 3.3% and Estee Lauder climbed 4.2% after both companies reported stronger-than-expected quarterly earnings. The S&P 500 added 0.6% to its all-time high, while the Dow Jones gained 226 points and the Nasdaq composite rose 0.7%. Colgate-Palmolive also beat estimates, though its CEO warned of continued volatile macroeconomic conditions. Easing oil prices helped steady markets amid uncertainty related to the Iran war.
